Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

French team disqualified from the Olympics
eventing
Following the French team's disqualification, Canada now qualifies for Rio 2016 (generic image)
Horse tests positive for banned sedative

A French eventing team has lost its spot in the 2016 Olympic Games in Rio after one of its horses tested positive for a controlled medication substance.

Samples taken from the horse, Qalao des Mers, in August last year found Hydroxyethylpromazine sulfoxide. The substance is a metabolite of the sedative, Acepromazine, which is on the FEI prohibited substances list.

Controlled medications are defined as those that are commonly used to treat horses, but are prohibited in competitions to maintain fairness.

The horse and its rider, Maxime Livio, were disqualified along with their team from the eventing competition at the FEI World Equestrian Games 2014.

The FEI Tribunal will make a final decision on further sanctions at a later date.

Livio came fifth in the individual rankings and the team finished fourth in Normandy, securing their slot in the Olympic Games.

Following the French team's disqualification, the Canadian eventing team has moved up to sixth place and qualifies for Rio 2016. Other nations so far competing in next year's games are Great Britain, Ireland, Germany, Australia, the Netherlands and Brazil as the host country.

Another case against Livio was dropped earlier this month. A borrowed horse ridden by Livio at a jumping event in Thailand last November initially tested positive but a second sample failed to confirm this.



Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.